These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22348492)

  • 1. Efficacy of intermediate-dose oral erythromycin on very low birth weight infants with feeding intolerance.
    Ng YY; Su PH; Chen JY; Quek YW; Hu JM; Lee IC; Lee HS; Chang HP
    Pediatr Neonatol; 2012 Feb; 53(1):34-40. PubMed ID: 22348492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants.
    Ng PC; Lee CH; Wong SP; Lam HS; Liu FY; So KW; Lee CY; Fok TF
    Gastroenterology; 2007 May; 132(5):1726-39. PubMed ID: 17484870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral erythromycin for treatment of feeding intolerance in preterm infants: a preliminary report.
    Sekteera W; Nuntnarumit P; Supapannachart S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1177-82. PubMed ID: 12549792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants.
    Nuntnarumit P; Kiatchoosakun P; Tantiprapa W; Boonkasidecha S
    J Pediatr; 2006 May; 148(5):600-5. PubMed ID: 16737869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC; So KW; Fung KS; Lee CH; Fok TF; Wong E; Wong W; Cheung KL; Cheng AF
    Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F177-82. PubMed ID: 11320044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities.
    Gokmen T; Oguz SS; Bozdag S; Erdeve O; Uras N; Dilmen U
    J Perinatol; 2012 Feb; 32(2):123-8. PubMed ID: 21566568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC
    Neonatology; 2009; 95(2):97-104. PubMed ID: 19218823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing enteral feeding in preterm infants with feeding intolerance: a randomized controlled study of low-dose erythromycin.
    Ng SC; Gomez JM; Rajadurai VS; Saw SM; Quak SH
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):554-8. PubMed ID: 14581796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin for feeding intolerance in preterm infants.
    Ng E; Shah V
    Cochrane Database Syst Rev; 2000; (2):CD001815. PubMed ID: 10796273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
    Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
    Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin for feeding intolerance in preterm infants.
    Ng E; Shah V
    Cochrane Database Syst Rev; 2001; (2):CD001815. PubMed ID: 11406010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of risk factors for parenteral nutrition-associated cholestasis in preterm infants: a multicenter observational study.
    Wang YS; Shen W; Yang Q; Lin R; Tang LX; Bai RM; Yang D; Zhang J; Zhang YJ; Yu WT; Song SR; Kong J; Song SY; Mao J; Tong XM; Li ZK; Wu F; Lin XZ
    BMC Pediatr; 2023 May; 23(1):250. PubMed ID: 37210514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of erythromycin on feeding intolerance in very low birth weight infants: a preliminary observation.
    Su BH; Lin HC; Peng CT; Tsai CH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1998; 39(5):324-6. PubMed ID: 9823678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin and feeding intolerance in premature infants: a randomized trial.
    Aly H; Abdel-Hady H; Khashaba M; El-Badry N
    J Perinatol; 2007 Jan; 27(1):39-43. PubMed ID: 17036029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of early parenteral nutrition cycling to prevent cholestasis in very low birth weight infants.
    Salvador A; Janeczko M; Porat R; Sekhon R; Moewes A; Schutzman D
    J Pediatr; 2012 Aug; 161(2):229-33.e1. PubMed ID: 22424948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants.
    Mansi Y; Abdelaziz N; Ezzeldin Z; Ibrahim R
    Neonatology; 2011; 100(3):290-4. PubMed ID: 21701222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early enteral feeding in very low birth weight infants.
    Hamilton E; Massey C; Ross J; Taylor S
    Early Hum Dev; 2014 May; 90(5):227-30. PubMed ID: 24612934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pioneering study: oral clarithromycin treatment for feeding intolerance in very low birth weight preterm infants.
    Sancak S; Gursoy T; Tuten A; Arman D; Karatekin G; Ovali F
    J Matern Fetal Neonatal Med; 2018 Apr; 31(8):988-992. PubMed ID: 28279123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with early enteral feeding in very-low-birth-weight infants.
    Wang LY; Hung HY; Hsu CH; Kao HA; Huang FY
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(4):282-7. PubMed ID: 9297929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous low-dose erythromycin administration for infants with feeding intolerance.
    Nogami K; Nishikubo T; Minowa H; Uchida Y; Kamitsuji H; Takahashi Y
    Pediatr Int; 2001 Dec; 43(6):605-10. PubMed ID: 11737737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.